Therapeutics Therapeutics Home Tools Email Share How would you like to share? Facebook Twitter LinkedIn Back to the Top Find a Therapeutic By Name Go AAB-003 AADvac1 AAVrh.10-APOE2 ABBV-0805 ABT 418 ABT-089 ABT-288 ABT-384 ABT-957 ABvac 40 Acetyl-l-carnitine HCI ACI-24 ACI-3024 ACI-35 Acitretin Aducanumab AF 102B Affitope AD02 Affitope PD01A AGB101 AL001 AL002 AL003 Allopregnanolone Alpha-Tocopherol ALZ-801 Alzhemed™ ALZT-OP1 Ambroxol Amilomotide AMX0035 AN-1792 Anle138b Apabetalone Aripiprazole ASN120290 Atabecestat ATH-1017 Atomoxetine Atorvastatin Atuzaginstat Avagacestat AVP-786 AVP-923 AXS-05 AZD1446 AZD3480 Azeliragon AZP2006 Bapineuzumab Bepranemab Besipirdine HCl Bexarotene BI 1181181 BI 409306 BI 425809 Bifidobacterium breve A1 BIIB076 BIIB080 BIIB094 BIIB118 Blarcamesine Bosutinib BPN14770 Brexpiprazole Bryostatin 1 Candesartan Carvedilol CDNF Celecoxib CERE-110 Cerebrolysin CHF 5074 Cinpanemab Circadin Citalopram Clioquinol CNM-Au8 COGNIShunt™ Continuous Positive Airway Pressure Crenezumab Curcumin CVN424 CX516 Dapagliflozin Dapsone Davunetide DAYVIGO Deep Brain Stimulation-fornix Deferiprone Dexpramipexole Dimebon DNL151 DNL201 DNL343 DNL747 Docosahexaenoic acid (DHA) Donanemab Donepezil E2027 E2814 Edicotinib Edonerpic EHT 0202 Elayta Elenbecestat ELND005 Empagliflozin Encenicline Epigallocatechin Gallate (EGCG) Epothilone D Eptastigmine Estrogen Etanercept EVP-0962 Exendin-4 Flurizan™ FRM-0334 G-CSF Galantamine Gammagard® Gamunex Gantenerumab GC 021109 Gemfibrozil GENUS GLN-1062 GM-CSF Leukine Gosuranemab GRF6019 GSK239512 GSK2647544 GSK933776 Guanfacine GV-971 GV1001 HF0220 HTL0018318 Huperzine A Ibuprofen Idalopirdine Idebenone Intepirdine Inzomelid JNJ-63733657 Ketasyn kMCT-ONS Kynmobi Ladostigil Lanabecestat Lecanemab Leuprolide Levetiracetam Linopirdine Liraglutide LM11A-31-BHS LMTM Lornoxicam Losartan LTI-291 Lu AF20513 LU AF82422 Lu AF87908 LU25-109 Lumateperone LY2599666 LY2886721 LY3202626 LY3372689 LY3372993 Masitinib Masupirdine MEDI1341 MEDI1814 Melatonin MEM 1003 Memantine Metformin Methylphenidate Metrifonate Mevidalen Milameline Minocycline MK-7622 MKC-231 Montelukast MSDC-0160 MW151 Naproxen Nasal Insulin Nefiracetam Neflamapimod Nelonicline Nelotanserin NeoTrofin Neramexane NGX267 NIC5-15 Nicotinamide Nilotinib Nilvadipine Nimodipine NPT520-34 NS2330 Octagam®10% ORM-12741 PBT2 Pepinemab PF-05212377 PF-06648671 PF-06751979 PF-06852231 Phenserine Physostigmine Salicylate Pimavanserin Pioglitazone Piromelatine PNT001 Ponezumab Posiphen PR001 PR006 Prasinezumab Prazosin Prednisone PRI-002 Propentofylline PRX-03140 PU-AD PXT864 Rasagiline Rember TM Repetitive Transcranial Magnetic Stimulation Resveratrol RG3487 RG7129 RG7345 Rilapladib Riluzole Rivastigmine RO7126209 Rofecoxib Rosiglitazone Rotigotine S 38093 S-Equol S47445 Sabeluzole SAR110894D SAR228810 Saracatinib SB 202026 Semagacestat Semaglutide Sembragiline Semorinemab SGS-742 Simvastatin Solanezumab Souvenaid ST101 Sumifilam Suritozole SUVN-G3031 Suvorexant T3D-959 Tacrine Telmisartan Thalidomide Tideglusib Tilavonemab Tofersen TPI 287 Tricaprilin Troriluzole UB-311 Umibecestat Vafidemstat Valacyclovir Valproate Vanutide cridificar Varenicline Varoglutamstat Vascepa Venglustat Verubecestat VY-AADC Xaliproden Xanamem XPro1595 Young Plasma YTX-7739 Zagotenemab Other Search By Attributes FDA Status Phase 1 Phase 1/2 Phase 2 Phase 2/3 Phase 3 Phase 4 Approved Inactive Discontinued Not Regulated Target Type alpha-synuclein Amyloid-Related Cholesterol Cholinergic System Inflammation Metals Other Other Neurotransmitters Tau Unknown Therapy Type Combination DNA/RNA-based Immunotherapy (active) Immunotherapy (passive) Other Procedural Intervention Small Molecule Supplement, Dietary Condition Alzheimer's Disease Amyotrophic Lateral Sclerosis Cerebral Amyloid Angiopathy Frontotemporal Dementia Mild Cognitive Impairment Parkinson's Disease Keyword 0 Therapeutics View Results Reset Search Results Name Synonyms FDA Status Company Target Type Therapy Type Approved For
